HROW FY 2024 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

FY 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$200M+53.3% YoY

Gross Profit

$150M75.3% margin

Operating Income

$9M4.4% margin

Net Income

-$17M-8.8% margin

EPS (Diluted)

$-0.49

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$61M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$389M

Total Liabilities

$320M

Stockholders' Equity

$70M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$200M	$130M	+53.3%
Gross Profit	$150M	$91M	+66.1%
Operating Income	$9M	$431,000	+1946.9%
Net Income	-$17M	-$24M	+28.4%